Off label use, Swelling, Skin mass
Drugs: STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT
- Safetyreportversion
- 1
- Safetyreportid
- 26475172
- Primarysourcecountry
- US
- Transmissiondateformat
- 102
- Transmissiondate
- 20260415
- Reporttype
- 1
- Serious
- 1
- Seriousnessdeath
- 2
- Seriousnesslifethreatening
- 2
- Seriousnesshospitalization
- 2
- Seriousnessdisabling
- 2
- Seriousnesscongenitalanomali
- 2
- Seriousnessother
- 1
- Receivedateformat
- 102
- Receivedate
- 20260306
- Receiptdateformat
- 102
- Receiptdate
- 20260306
- Fulfillexpeditecriteria
- 3
- Authoritynumb
- FDA-CDER-CTU-2026-14330
- Primarysource
- Reportercountry
- US
- Qualification
- 3
- Sender
- Sendertype
- 6
- Senderorganization
- FDA-CTU
- Receiver
- Receivertype
- 6
- Receiverorganization
- FDA
- Patient
- Patientonsetage
- 43
- Patientonsetageunit
- 801
- Patientweight
- 51.26
- Patientsex
- 2
- Reaction
- Reactionmeddraversionpt
- 28.1
- Reactionmeddrapt
- Off label use
- Reactionmeddraversionpt
- 28.1
- Reactionmeddrapt
- Swelling
- Reactionmeddraversionpt
- 28.1
- Reactionmeddrapt
- Skin mass
- Drug
- Drugcharacterization
- 1
- Medicinalproduct
- STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT
- Drugadditional
- 4
- Activesubstance
- Activesubstancename
- STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCTS
- Summary
- Narrativeincludeclinical
- CASE EVENT DATE: 20260306
